down arrow

Instil Bio, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45783C2008
USD
11.39
0.62 (5.71%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

11.2111.73

52 Week

10.7042.79
Valuation
Technical
Day's Volume

CASH

67.4 k

Shareholding (Mar 2025)

FII

2.89%

Held by 27 FIIs

DII

42.25%

Held by 11 DIIs

Promoter

44.86%

How big is Instil Bio, Inc.?

22-Jun-2025

As of Jun 18, Instil Bio, Inc. has a market capitalization of 182.69 million, with net sales of 0.00 million and a net profit of -78.03 million for the latest four quarters. Shareholder's funds are 169.44 million, and total assets are 264.76 million.

As of Jun 18, Instil Bio, Inc. has a market capitalization of 182.69 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -78.03 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds of 169.44 million and Total Assets of 264.76 million.

Read More

What does Instil Bio, Inc. do?

22-Jun-2025

Instil Bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $28 million and a market cap of $182.69 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -33.34%.

Overview: <BR>Instil Bio, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -28 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 182.69 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.12 <BR>Return on Equity: -33.34% <BR>Price to Book: 1.26<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Instil Bio, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Instil Bio, Inc. shows a mildly bullish trend based on daily moving averages and monthly indicators, but its overall performance remains concerning with a 1-year return of -68.18% compared to the S&P 500's 17.14%.

As of 11 September 2025, the technical trend for Instil Bio, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the monthly MACD and Bollinger Bands also support this bullish outlook. However, the weekly MACD, KST, and Dow Theory are all mildly bearish, creating a mixed signal overall. <BR><BR>In terms of performance, the stock has underperformed against the S&P 500 across multiple periods, notably with a 1-year return of -68.18% compared to the S&P 500's 17.14%. This suggests that while there are some bullish indicators, the overall performance remains concerning.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 174 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

-34.00%

stock-summary
Price to Book

1.32

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-60.71%
0%
-60.71%
6 Months
-61.89%
0%
-61.89%
1 Year
-57.47%
0%
-57.47%
2 Years
65.87%
0%
65.87%
3 Years
811.6%
0%
811.6%
4 Years
-97.14%
0%
-97.14%
5 Years
0%
0%
0.0%

Instil Bio, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Instil Bio, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for Instil Bio, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the monthly MACD and Bollinger Bands also support this bullish outlook. However, the weekly MACD, KST, and Dow Theory are all mildly bearish, creating a mixed signal overall. In terms of performance, the stock has underperformed against the S&P 500 across multiple periods, notably with a 1-year return of -68.18% compared to the S&P 500's 17.14%. This suggests that while there are some bullish indicators, the overall performance remains concerning....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.27%
EBIT Growth (5y)
8.86%
EBIT to Interest (avg)
-28.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.49
EV to EBIT
-3.89
EV to EBITDA
-4.15
EV to Capital Employed
1.56
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-40.06%
ROE (Latest)
-33.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 10 Schemes (10.0%)

Foreign Institutions

Held by 27 Foreign Institutions (2.89%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -43.62% vs 20.32% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.90",
          "val2": "-12.60",
          "chgp": "-2.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.60",
          "val2": "2.00",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.50",
          "val2": "-0.50",
          "chgp": "-2,000.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.40",
          "val2": "-14.90",
          "chgp": "-43.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 52.53% vs 30.06% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-56.30",
          "val2": "-85.80",
          "chgp": "34.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.00",
          "val2": "5.20",
          "chgp": "73.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.60",
          "val2": "-68.60",
          "chgp": "80.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-74.10",
          "val2": "-156.10",
          "chgp": "52.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-12.90
-12.60
-2.38%
Interest
1.60
2.00
-20.00%
Exceptional Items
-10.50
-0.50
-2,000.00%
Consolidate Net Profit
-21.40
-14.90
-43.62%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -43.62% vs 20.32% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-56.30
-85.80
34.38%
Interest
9.00
5.20
73.08%
Exceptional Items
-13.60
-68.60
80.17%
Consolidate Net Profit
-74.10
-156.10
52.53%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 52.53% vs 30.06% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Instil Bio, Inc. stock-summary
stock-summary
Instil Bio, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."